Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 2/2013

01-02-2013 | Letter to the Editor

Intravascular large B cell lymphoma presenting as anasarca: an unusual presentation of a rare lymphoma

Authors: Narat Srivali, Kunatum Prasidthratsint, Nischala Ammannagari, Wisit Cheungpasitporn, Patompong Ungprasert

Published in: Annals of Hematology | Issue 2/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Shimada K, Matsue KS, Yamamoto K et al (2008) Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26:3189–3195PubMedCrossRef
2.
Pfleger L, Tappeiner J (1959) On the recognition of systematized endotheliomatosis of the cutaneous blood vessels (reticuloendotheliosis?). Hautarzt 10:359–363PubMed
3.
Wick MR, Mills SE, Scheithauer BW, Cooper PH, Davitz MA, Parkinson K (1986) Reassessment of malignant “angioendotheliomatosis”. Evidence in favor of its reclassification as “intravascular lymphomatosis”. Am J Surg Pathol 10:112–123PubMedCrossRef
4.
Nakamura S, Ponzoni M, Campo E et al (2008) Intravascular large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL (eds) WHO classification of tumours of haematopoeitic and lymphoid tissues. IARC, Lyon, pp 252–253
5.
Ferreri AJ, Campo E, Seymour JF et al (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 127:173–183PubMedCrossRef
6.
Shimada K, Kinoshita T, Naoe T, Nakamura S (2009) Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol 10:895–902PubMedCrossRef
7.
Matsue K, Asada N, Odawara J et al (2011) Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma. Ann Hematol 90:417–421PubMedCrossRef
8.
Ferrari AJ, Dognini GP, Govi S et al (2008) Can rituximab change the usually dismal prognosis of patient with intravascular large B-cell lymphoma? J Clin Oncol 26:5134–5137CrossRef
Metadata
Title
Intravascular large B cell lymphoma presenting as anasarca: an unusual presentation of a rare lymphoma
Authors
Narat Srivali
Kunatum Prasidthratsint
Nischala Ammannagari
Wisit Cheungpasitporn
Patompong Ungprasert
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 2/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-012-1548-5

Other articles of this Issue 2/2013

Annals of Hematology 2/2013 Go to the issue

Original Article

Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K–562 with unmodified or chemically modified siRNAs and induction of apoptosis

Original Article

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload

Original Article

Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy

Letter to the Editor

Primary effusion anaplastic large cell lymphoma in a patient with long-standing dermatitis herpetiformis and celiac disease

Original Article

Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome

Original Article

Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits